IPC The Hospitalist Company (IPCM)
IPC The Hospitalist Company R&D Expense
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these IPCM related companies
IPCM News
IPC The Hospitalist Company, Inc. to Present at Bank of America Merrill Lynch 2012 Health Care Conference
May 09, 12:11PM GlobeNewswire
May 09, 12:11PM GlobeNewswire
IPC The Hospitalist Company, Inc. to Present at Deutsche Bank 37th Annual Health Care Conference
May 01, 4:01PM GlobeNewswire
May 01, 4:01PM GlobeNewswire
$IPCM forms bullish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/3W9W
about 35 days ago by RecogniaEvents
about 35 days ago by RecogniaEvents
$IPCM forms bullish "Bottom Triangle" chart pattern. http://stks.co/3W9Y
about 35 days ago by RecogniaEvents
about 35 days ago by RecogniaEvents
$IPCM is 5.5% up since open on unusual high volume and 8.6% up since close.
about 35 days ago by TradeBot
about 35 days ago by TradeBot
Listen to $IPCM Q1 2012 earnings call - live at 05:00 PM, ondemand after - http://stks.co/3UWq
about 36 days ago by earningscast
about 36 days ago by earningscast
Wells Fargo Starts IPC The Hospitalist Company (IPCM) at Market Perform; Growth Shift Toward Hiring Versus Acquiring
Apr 10, 10:24AM Street Insider
Apr 10, 10:24AM Street Insider
IPC The Hospitalist Company Completes Acquisition of Inpatient Clinical Solutions
Mar 20, 8:30AM GlobeNewswire
Mar 20, 8:30AM GlobeNewswire
IPC The Hospitalist Company Signs New Hospitalist Contracts With Methodist Healthcare -- San Antonio
Mar 08, 8:30AM GlobeNewswire
Mar 08, 8:30AM GlobeNewswire
IPC The Hospitalist Company Expands Continuum of Care With Behavioral Health Practice Acquisition
Mar 07, 8:30AM GlobeNewswire
Mar 07, 8:30AM GlobeNewswire
IPC The Hospitalist Company, Inc. to Present at RBC Capital Markets' Healthcare Conference
Feb 23, 4:00PM GlobeNewswire
Feb 23, 4:00PM GlobeNewswire
Listen to $IPCM Q4 2011 earnings call - live at 05:00 PM, ondemand after - http://stks.co/2V1L
about 99 days ago by earningscast
about 99 days ago by earningscast
IPC The Hospitalist Company (IPCM) Tops Q4 EPS by 4c; Guides FY12 Sales Above the Street
Feb 21, 4:15PM Street Insider
Feb 21, 4:15PM Street Insider
$IPCM Reports Q4 EPS $0.51 vs $0.47 Est; Revenues $117.90M vs $117.06M Est
about 99 days ago by Benzinga
about 99 days ago by Benzinga
IPC The Hospitalist Company Reports Fourth Quarter and Full Year 2011 Results
Feb 21, 4:00PM GlobeNewswire
Feb 21, 4:00PM GlobeNewswire
@gtotoy @traderstewie Either of you have time for a look at $IPCM and $JVA? Thanks!
about 104 days ago by Val_U_Investor
about 104 days ago by Val_U_Investor
IPC The Hospitalist Company Signs Definitive Agreement to Acquire South Florida Practice
Feb 14, 5:00PM GlobeNewswire
Feb 14, 5:00PM GlobeNewswire
IPC The Hospitalist Company, Inc. to Report Fourth Quarter 2011 Results
Feb 06, 4:01PM GlobeNewswire
Feb 06, 4:01PM GlobeNewswire
IPC The Hospitalist Company, Inc. to Present at the UBS 22nd Annual Global Healthcare Services Conference
Feb 02, 9:35AM GlobeNewswire
Feb 02, 9:35AM GlobeNewswire
$IPCM New 52 Week Low - Crossed daily lows support. Next support 29.665 from 10/28/2010.
about 141 days ago by TradeIdeasQuant
about 141 days ago by TradeIdeasQuant
Hospitalist play $IPCM lowers 4Q outlook - cites encounters "soft" during the qtr
about 145 days ago by djacome
about 145 days ago by djacome
$IPCM shares down 7-8% AH: cuts FY11 sales from $463-$465M to $455-$458M, EPS from $1.78-$1.86 to $1.70-$1.74; sees Q4 sales $115-$118M
about 145 days ago by Street_Insider
about 145 days ago by Street_Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| IPCM | 35.21 | -0.23 | -0.65% | 585.47M |
| IPCI | 2.96 | +0.00 | +0.00% | 47.09M |
| IPCC | 54.19 | -0.42 | -0.77% | 644.40M |
| IPAS | 2.35 | -0.03 | -1.26% | 141.06M |
| IPAR | 15.45 | -0.29 | -1.84% | 481.01M |
| IP | 29.30 | -0.62 | -2.07% | 13.08B |
| IOT | 1.67 | -0.06 | -3.47% | 6.964M |
| IOSP | 26.46 | -0.85 | -3.11% | 630.04M |
| IHS | 100.20 | -1.50 | -1.47% | 6.629B |
| IHI | 63.13 | -1.02 | -1.59% |
